Cargando…

Sarcopenia predicts an adverse prognosis in patients with combined hepatocellular carcinoma and cholangiocarcinoma after surgery

BACKGROUND: The prognostic value of sarcopenia in combined hepatocellular carcinoma and cholangiocarcinoma (cHCC‐CC) patients after surgery has not been evaluated, while the efficacy of the available tumor stage for cHCC‐CC remains controversial. METHODS: All consecutive cHCC‐CC patients after surge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Gui‐min, Jiang, Chuang, Du, Jin‐peng, Yuan, Ke‐fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8729053/ https://www.ncbi.nlm.nih.gov/pubmed/34866356 http://dx.doi.org/10.1002/cam4.4448

Ejemplares similares

Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular‐cholangiocarcinoma after resection
por: Song, Peipei, et al.
Publicado: (2019)

The prognostic value of sarcopenia combined with preoperative fibrinogen–albumin ratio in patients with intrahepatic cholangiocarcinoma after surgery: A multicenter, prospective study
por: Yu, Haitao, et al.
Publicado: (2021)

Survival outcomes of combined hepatocellular‐cholangiocarcinoma compared with intrahepatic cholangiocarcinoma: A SEER population‐based cohort study
por: Yang, Zhen, et al.
Publicado: (2021)

Nomogram based on inflammatory indices for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma
por: Chen, Lang, et al.
Publicado: (2020)

A nomogram incorporating six easily obtained parameters to discriminate intrahepatic cholangiocarcinoma and hepatocellular carcinoma
por: Wang, Mengmeng, et al.
Publicado: (2018)

T cell receptor repertoire profiling predicts the prognosis of HBV‐associated hepatocellular carcinoma
por: Lin, Kai‐Rong, et al.
Publicado: (2018)

Sarcopenia and adverse health‐related outcomes: An umbrella review of meta‐analyses of observational studies
por: Xia, Lin, et al.
Publicado: (2020)

Muscle weakness as an additional criterion for grading sarcopenia‐related prognosis in patients with cancer
por: Cereda, Emanuele, et al.
Publicado: (2021)

Aberrant MCT4 and GLUT1 expression is correlated with early recurrence and poor prognosis of hepatocellular carcinoma after hepatectomy
por: Chen, Hai‐Long, et al.
Publicado: (2018)

Outcome of Combined Hepatocellular and Cholangiocarcinoma of the Liver
por: Wang, Jue, et al.
Publicado: (2010)

Statin use and the prognosis of patients with hepatocellular carcinoma: a meta-analysis
por: Li, Xiaofei, et al.
Publicado: (2020)

Association of TIP30 expression and prognosis of hepatocellular carcinoma in patients with HBV infection
por: Zhang, Xia, et al.
Publicado: (2016)

Therapeutic potential and adverse events of everolimus for treatment of hepatocellular carcinoma – systematic review and meta-analysis
por: Yamanaka, Kenya, et al.
Publicado: (2013)

Axl and autophagy LC3 expression in tumors is strongly associated with clinical prognosis of hepatocellular carcinoma patients after curative resection
por: Hsu, Chia‐Chang, et al.
Publicado: (2019)

Exophytic combined hepatocellular carcinoma and cholangiocarcinoma
por: Noh, Sang Jae, et al.
Publicado: (2012)

Contrast-enhanced ultrasound imaging features and clinical characteristics of combined hepatocellular cholangiocarcinoma: comparison with hepatocellular carcinoma and cholangiocarcinoma
por: Zhang, Hai-Chun, et al.
Publicado: (2020)

Influence of cirrhosis on long-term prognosis after surgery in patients with combined hepatocellular-cholangiocarcinoma
por: Zhou, Yan-Ming, et al.
Publicado: (2017)

Prognostic significance of sarcopenia in upper tract urothelial carcinoma patients treated with radical nephroureterectomy
por: Fukushima, Hiroshi, et al.
Publicado: (2016)

FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma
por: Zhong, Cheng‐Qian, et al.
Publicado: (2018)

Prediction of prognosis of patients with lung cancer in combination with the immune score
por: Han, Ke, et al.
Publicado: (2021)

Hyperthermia ablation combined with transarterial chemoembolization versus monotherapy for hepatocellular carcinoma: A systematic review and meta‐analysis
por: Li, Zheng, et al.
Publicado: (2021)

Down-regulation of RBP4 indicates a poor prognosis and correlates with immune cell infiltration in hepatocellular carcinoma
por: Li, Mingxing, et al.
Publicado: (2021)

Prognosis of patients with hepatocellular carcinoma treated with sorafenib: a comparison of five models in a large Canadian database
por: Samawi, Haider H., et al.
Publicado: (2018)

Nomograms to predict the long‐time prognosis in patients with alpha‐fetoprotein negative hepatocellular carcinoma following radical resection
por: Huang, Jian, et al.
Publicado: (2020)

The influence of venous tumor thrombus combined with bland thrombus on the surgical treatment and prognosis of renal cell carcinoma patients
por: Liu, Zhuo, et al.
Publicado: (2020)

Serum exosomal microRNAs combined with alpha‐fetoprotein as diagnostic markers of hepatocellular carcinoma
por: Wang, Yurong, et al.
Publicado: (2018)

Immunotherapies for hepatocellular carcinoma
por: Liu, Justin K. H., et al.
Publicado: (2021)

Rapid progression of combined hepatocellular carcinoma and cholangiocarcinoma
por: Saboo, Sachin S., et al.
Publicado: (2011)

Pathology of Combined Hepatocellular Carcinoma-Cholangiocarcinoma: An Update
por: Roßner, Florian, et al.
Publicado: (2023)

Genomic Profiling of Combined Hepatocellular Cholangiocarcinoma Reveals Genomics Similar to Either Hepatocellular Carcinoma or Cholangiocarcinoma
por: Murugesan, Karthikeyan, et al.
Publicado: (2021)

Impact of bromodomain‐containing protein 4 (BRD4) and intestine‐specific homeobox (ISX) expression on the prognosis of patients with hepatocellular carcinoma' for better clarity
por: Chuang, Kai‐Ting, et al.
Publicado: (2021)

Low expression of long noncoding RNA CTC‐297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma
por: Zhu, Sicong, et al.
Publicado: (2019)

Sulfiredoxin‐1 is a promising novel prognostic biomarker for hepatocellular carcinoma
por: Rao, Qian‐Wen, et al.
Publicado: (2020)

Role of autophagy-related protein in the prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgical resection
por: Perng, Daw-Shyong, et al.
Publicado: (2021)

Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV‐related hepatocellular carcinoma
por: Ding, Yezhou, et al.
Publicado: (2020)

Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma
por: Elganainy, Dalia, et al.
Publicado: (2018)

Genomewide identification of a novel six‐LncRNA signature to improve prognosis prediction in resectable hepatocellular carcinoma
por: Wu, Ying, et al.
Publicado: (2018)

Predictive factors of early recurrence after R0 resection of hilar cholangiocarcinoma: A single institution experience in China
por: Hu, Hai‐Jie, et al.
Publicado: (2019)

Prognostic value of Notch receptors in postsurgical patients with hepatitis B virus‐related hepatocellular carcinoma
por: Yu, Tingdong, et al.
Publicado: (2017)

Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma
por: Renzulli, Matteo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_363u8tvb556gbshqq15f7jov3l